No takes yet. Share an insight, caveat, or question.
Systematic review reveals divergent neurological outcomes between anti-Yo degeneration and anti-NMDAR encephalitis in ovarian tumors, highlighting persistent deficits in cancer patients.
Zahorowska et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: